Free Trial

Ardent Health Partners, LLC (NYSE:ARDT) Shares Sold by Two Sigma Investments LP

Ardent Health Partners logo with Medical background

Two Sigma Investments LP cut its position in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) by 53.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 24,841 shares of the company's stock after selling 27,972 shares during the quarter. Two Sigma Investments LP's holdings in Ardent Health Partners were worth $424,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in ARDT. Point72 Asia Singapore Pte. Ltd. bought a new position in Ardent Health Partners during the fourth quarter worth $27,000. US Bancorp DE bought a new position in Ardent Health Partners during the fourth quarter worth $31,000. New York State Common Retirement Fund bought a new position in Ardent Health Partners during the fourth quarter worth $48,000. Deutsche Bank AG lifted its stake in Ardent Health Partners by 1,251.9% during the fourth quarter. Deutsche Bank AG now owns 2,866 shares of the company's stock worth $49,000 after purchasing an additional 2,654 shares during the last quarter. Finally, Wells Fargo & Company MN lifted its stake in Ardent Health Partners by 52.6% during the fourth quarter. Wells Fargo & Company MN now owns 8,704 shares of the company's stock worth $149,000 after purchasing an additional 3,002 shares during the last quarter.

Ardent Health Partners Stock Performance

Shares of NYSE ARDT traded down $0.41 during midday trading on Friday, reaching $13.14. 267,142 shares of the company traded hands, compared to its average volume of 384,426. Ardent Health Partners, LLC has a 52 week low of $11.31 and a 52 week high of $20.72. The stock has a 50-day moving average price of $13.60 and a 200 day moving average price of $14.50. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The company has a market cap of $1.88 billion and a price-to-earnings ratio of 8.06.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, beating analysts' consensus estimates of $0.21 by $0.08. The company had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.50 billion. Sell-side analysts anticipate that Ardent Health Partners, LLC will post 1.23 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently issued reports on ARDT. Royal Bank of Canada restated an "outperform" rating and set a $21.00 price objective on shares of Ardent Health Partners in a research note on Thursday, May 15th. Guggenheim raised their target price on Ardent Health Partners from $16.00 to $18.00 and gave the company a "buy" rating in a research note on Friday, May 9th. Mizuho cut their target price on Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Finally, Stephens reiterated an "overweight" rating and issued a $21.00 target price on shares of Ardent Health Partners in a research note on Tuesday, May 20th. Two equities research analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $20.67.

View Our Latest Research Report on ARDT

Ardent Health Partners Company Profile

(Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Featured Stories

Institutional Ownership by Quarter for Ardent Health Partners (NYSE:ARDT)

Should You Invest $1,000 in Ardent Health Right Now?

Before you consider Ardent Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.

While Ardent Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines